Table 4.
Subject (electrolyte) | Baseline | Day 7 | day 42 | |
---|---|---|---|---|
19 | Na+ | 18.8 | 110.6 | 55 |
K+ | 15.8 | 27.3 | 16.3 | |
Cl− | 22.6 | 109.9 | 57 | |
50 | Na+ | 12.8 | 35.2 | 83 |
K+ | 12.9 | 10.6 | 16.7 | |
Cl− | 17.1 | 36.2 | 81.3 | |
99 a | Na+ | 4.1 | 37.9 | 0.0 |
K+ | 18.5 | 22 | 25.6 | |
Cl− | ND | 40.1 | 22.2 | |
103b | Na+ | 0.0 | 7.7 | 0.0 |
K+ | 22 | 24.5 | 20.6 | |
Cl− | 10.2 | 19 | 12.1 | |
118 c | Na+ | 0.9 | 4.3 | 2.7 |
K+ | 21.9 | 25.8 | 29.9 | |
Cl− | 14.6 | ND | 19.5 |
The gray shaded areas represent electrolyte concentrations (mM) in samples from the subject’s initial peak flow, i.e., day 7 for # 19 and day 42 for # 50. ND = not determined.
The initial peak flow rate for this subject was on day 14. The day 7 flow was 0.24 ml/min/gland, and was substantially above baseline (0.092).
The initial peak flow rate for this subject was on day 28. The day 7 flow was 0.184 ml/min/gland, 36% above baseline (0.135).
The initial peak flow for this subject was on day 28. The day 7 flow was 0.058 ml/min/gland, 31% above baseline (0.044).